Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, May 2004, p. 618-620, Vol. 11, No. 3
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.3.618-620.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Evaluation of Commercial Immunoassays for Detection of Antibody against Helicobacter pylori in Thai Dyspeptic Patients
Orrawadee Hanvivatvong,1* Atinop Pongpanich,1 Duangporn Thong-Ngam,2 Niramol Thammacharoenrach,1 and Pinit Kullavanijaya3
Department of Microbiology,1
Department of Physiology,2
Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand3
Received 16 October 2003/
Returned for modification 12 December 2003/
Accepted 12 February 2004

ABSTRACT
The performance of five immunoassays for detection of immunoglobulin
G antibody against
Helicobacter pylori in 191 dyspeptic patients
was evaluated. The sensitivities, specificities, accuracies,
positive predictive values, and negative predictive values ranged
from 86.32 to 97.89%, 57.95 to 72.22%, 77.02 to 83.76%, 71.54
to 77.42%, and 83.33 to 96.23%, respectively. The immunoglobulin
A test kit also gave a high sensitivity and negative predictive
value (95.79 and 91.40%, respectively), while the specificity
was relatively low (51.14%).

TEXT
Serological assay for
Helicobacter pylori antibody is a noninvasive
method to detect
H. pylori infection. It has been reported to
have sensitivity and specificity in predicting the status of
H. pylori infection in untreated patients as accurately as invasive
tests (
11,
12). However, it has been suggested that serological
tests for
H. pylori should be locally validated (
7), because
assays validated in one region may yield variable diagnostic
performances in others. These variations may be attributed to
many factors, including the source of antigen used, the prevalence
of infection in each population studied, and the reference method
used to determine true
H. pylori infection status. Therefore,
reevaluation is needed before implementing a test in different
populations. In Thailand, the seroprevalence of
H. pylori infection
has been reported to be higher than that in industrialized countries
(
10), and commercially available enzyme immunoassay (EIA) test
kits have been reported to have lower sensitivities and specificities
compared to in-house EIAs in Thai dyspeptic patients (
1). We
therefore evaluated the performance of five commercial test
kits for detecting of immunoglobulin G (IgG) antibody to
H. pylori. Three of them use a standard enzyme-linked immunosorbent
assay (Cobas Core anti-
H. pylori EIA [Roche, Mannheim, Germany];
Pyloriset EIA-GIII [Orion, Espoo, Finland]; and Enzygnost anti-
H. pylori II/IgG [Dade Behring, Marburg, Germany]), and two are
rapid assay test kits (Pyloriset Dry [Orion] and anti-
H. pylori IgG Immunocomb [Orgenics, Yavne, Israel]). One
H. pylori IgA
antibody test kit (Pyloriset EIA-AIII) was also evaluated.
A total of 191 patients (57 males and 134 females; age range, 16 to 83 years [mean, 39 years]) were studied. Endoscopy was performed in all patients, and 183 (95.81%) of them were diagnosed as having nonulcer dyspepsia while the remaining 8 patients (4.19%) had a duodenal ulcer. Patients who received antibiotic therapy, bismuth treatment, or a proton pump inhibitor or H2 blocker within 1 month prior to the study were excluded. Written informed consent was obtained from all patients before the study. Five milliliters of clotted blood was obtained on the day of endoscopy. Sera were kept at 20°C until analyzed. The biopsy specimens from the antrum and stomach body were obtained for rapid urease (CLO) test and histological and cultural examination. All the tests were performed according to the manufacturer's instructions and without the knowledge of the status of the patient's infection. The results of these examinations were described previously (4).
In this study, a patient was considered infected with H. pylori when either culture was positive or both rapid urease (CLO) test and histological analysis were positive.
Statistic analyses for sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated against the status of H. pylori infection. As shown in Table 1, the three standard EIAs for IgG antibody gave a similar higher sensitivity (95.95 to 97.89%) and negative predictive value (92.06 to 96.23%) when compared to the rapid immunoassays. The specificity of all tests was considered low (57.95 to 69.57%), while the accuracy was similar, with the highest at 83.76% by Cobas Core anti-H. pylori EIA. The agreement between each test as analyzed by kappa statistic was relatively high among the standard immunoassays. Pyloriset Dry gave the lowest agreement with other tests, especially with Immunocomb (Table 2).
As reported by other investigators who have found that Western
antigen-based serology has relatively poor performance with
samples from Asian groups (
5,
6,
8), we also found a low specificity
of these tests in our study. The possible reasons may be due
to the high prevalence rate of
H. pylori infection in the Thai
population (
10). Therefore, the presence of antibody in some
sera may reflect past infection. Furthermore, the results of
validation are highly dependent on the reliability of the reference
method used, and it is generally accepted that all the tests
for
H. pylori have their pitfalls and limitations that may affect
the status of infection. In this study, the status of infection
depended on the results of culture or histology and rapid urease
(CLO) test. We observed that 10 out of 35 seropositive (as demonstrated
by at lease two serological tests used in this study) patients
in the 92 noninfected groups were concomitantly positive by
histology or urease test. Most of them had higher antibody levels
than those who were positive by serology alone, as shown in
Fig.
1. Therefore, it is possible that some patients of the
group may have had
H. pylori infection during the study period.
Figure
1 also demonstrates the distribution of
H. pylori IgG
antibody levels in the
H. pylori-infected and noninfected patients.
The performance of the rapid tests was similar to that reported
previously (
2) in that they were slightly inferior to the standard
EIA tests. Although better results have also been reported (
9,
14), the use of rapid tests has not been recommended (
7). However,
these tests are easy to perform and can be finished within a
few minutes without the need of sophisticated equipment. By
using these tests and with careful interpretation, the physician
can determine
H. pylori infection of a patient at the first
consultation.
Anti-H. pylori IgA antibody was found in 91 out of 95 (95.79%) H. pylori-infected patients (Table 1). Almost all, except one, were also found to have IgG antibody (by Pyloriset EIA-GIII) in their serum. Combining the results of this Pyloriset EIA-AIII and Pyloriset EIA-GIII slightly increased the sensitivity and the negative predictive value, but the specificity was markedly decreased (data not shown). Although anti-H. pylori IgA antibody has been reported to have diagnostic values when used in conjunction with IgG (3, 13), we agree with a previous report (12) that IgA had no additional diagnostic value in our clinical settings.
With regards to the high sensitivity and negative predictive values of the commercial H. pylori IgG antibody kits used in this study, we concluded that, with careful interpretation, these tests may be used as an alternative test for determining H. pylori infection, especially in those for whom gastroscopy cannot be performed.

ACKNOWLEDGMENTS
We thank Science Tech Co., Ltd., Bangkok, Thailand; Roche Diagnostic,
Ltd., Bangkok, Thailand; Firmer Co., Ltd., Bangkok, Thailand;
and Dade Behring, Bangkok, Thailand, for their support with
the test reagents.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Phone: 662 252 8181-3666. Fax: 662 252 5952. E-mail:
fmedohv{at}md2.md.chula.ac.th.


REFERENCES
1 - Bodhidatta, L., C. W. Hoge, S. Churnratanakul, W. Nirdnoy, P. Sampathanukul, C. Tungtaem, S. Raktham, C. D. Smith, and P. Echeverria. 1993. Diagnosis of Helicobacter pylori in a developing country: comparison of two ELISAs and a prevalence study. J. Infect. Dis. 168:1549-1553.[Medline]
2 - Chen, T. S., F. Y. Chang, and S. D. Lee. 2002. No difference of accuracy between capillary and venous blood in rapid whole blood test for diagnosis of Helicobacter pylori. Dig. Dis. Sci. 47:2519-2522.[CrossRef][Medline]
3 - Granberg, C., A. Mansikka, O. P. Lehtonen, H. Kujari, R. Gronfors, H. Nurmi, I. Raiha, M. R. Stahberg, and R. Leino. 1993. Diagnosis of Helicobacter pylori infection by using Pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J. Clin. Microbiol. 31:1450-1453.[Abstract/Free Full Text]
4 - Hanvivatvong, O., K. Tatiyakavee, D. Thong-Ngam, A. Pongpanich, C. Chirathaworn, P. Suwanagool, P. Nunthapisud, and P. Kullavanijaya. 2002. Detection of antibody in serum and secretion for the diagnosis of Helicobacter pylori infection. J. Med. Assoc. Thai. 85(Suppl. 1):S383-S388.
5 - Kim, S. Y., J. S. Ahn, Y. J. Ha, H. J. Doh, M. H. Jang, S. I. Chung, and H. J. Park. 1998. Serodiagnosis of Helicobacter pylori in Korean patients using enzyme-linked immunosorbent assay. J. Immunoassay 19:251-270.[Medline]
6 - Leung, W. K., E. K. Ng, F. K. Chan, S. C. Chung, and J. J. Sung. 1999. Evaluation of three commercial enzyme-linked immunosorbent assay kits for diagnosis of Helicobacter pylori in Chinese patients. Diagn. Microbiol. Infect. Dis. 34:13-17.[CrossRef][Medline]
7 - Malfertheiner, P., F. Megraud, C. O'Morain, A. P. Hungin, R. Jones, A. Axon, D. Y. Graham, G. Tytgat, et al. 2002. Current concepts in the management of Helicobacter pylori infectionthe Maastricht 2-2000 consensus report. Aliment. Pharmacol. Ther. 16:167-180.[Medline]
8 - Matsuo, K., N. Hamajima, S. Tominaga, T. Suzuki, T. Nakamura, and A. Matsuura. 2000. Helicobacter pylori IgG antibody test established in the United States showed a substantially lower sensitivity for Japanese population. Am. J. Gastroenterol. 95:1597-1598.[CrossRef][Medline]
9 - Oksanen, A., L. Veijola, P. Sipponen, K. O. Schauman, and H. Rautelin. 1998. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J. Clin. Microbiol. 36:955-957.[Abstract/Free Full Text]
10 - Perez-Perez, G. I., D. N. Taylor, L. Bodhidatta, J. Wongsrichanalai, W. B. Baze, B. E. Dunn, P. D. Echeverria, and M. J. Blaser. 1990. Seroprevalence of Helicobacter pylori infections in Thailand. J. Infect. Dis. 161:1237-1241.[Medline]
11 - Talley, N. J., D. G. Newell, J. E. Ormand, H. A. Carpenter, W. R. Wilson, A. R. Zinsmeister, G. I. Perez-Perez, and M. J. Blaser. 1991. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J. Clin. Microbiol. 29:1635-1639.[Abstract/Free Full Text]
12 - B. A. M. van de Wouw, W. A. de Boer, A. R. Jansz, R. T. J. M. Roymans, and A. P. G. Staals. 1996. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. J. Clin. Microbiol. 34:94-97.[Abstract]
13 - Von Wulffen, H., and H. J. Grote. 1988. Enzyme-linked immunosorbent assay for detection of immunoglobulin A and G antibodies to Campylobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 7:559-565.[CrossRef][Medline]
14 - Wong, W. M., S. K. Lam, H. H. Xia, V. S. Tang, K. C. Lai, W. H. Hu, D. K. Chan, K. L. Chung, and B. C. Wong. 2002. Accuracy of a new near patient test for the diagnosis of Helicobacter pylori infection in Chinese. J. Gastroenterol. Hepatol. 17:1272-1277.[CrossRef][Medline]
Clinical and Diagnostic Laboratory Immunology, May 2004, p. 618-620, Vol. 11, No. 3
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.3.618-620.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.